<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01056185</url>
  </required_header>
  <id_info>
    <org_study_id>0603M83587 FLU 003</org_study_id>
    <nct_id>NCT01056185</nct_id>
  </id_info>
  <brief_title>Respiratory Virus Hospitalization Study (FLU 003 Plus)</brief_title>
  <official_title>An International Observational Study to Characterize Adults Who Are Hospitalized With Influenza or Other Targeted Respiratory Viruses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota - Clinical and Translational Science Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Minnesota - Clinical and Translational Science Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Following the sudden and unexpected emergence of influenza A(H1N1)pdm09 (2009 H1N1) virus,
      this observational study was initiated to estimate rates of morbidity and mortality and to
      examine predictors of severity among participants with 2009 H1N1 infection. In 2011, as
      surveillance indicated that 2009 H1N1 virus was co-circulating with other seasonal influenza
      A and B viruses worldwide, the protocol was expanded to include other influenza A subtypes
      and influenza B viruses. The current version of the protocol (released in August 2013)
      further broadens the scope of this observational study. With the recognition that novel
      respiratory viruses other than novel influenza A viruses, e.g., Middle East Respiratory
      Syndrome Coronavirus (MERS-CoV), could become prevalent and of major public health
      importance, the objectives of this protocol have been expanded.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this observational study is to describe the characteristics and outcomes over
      a 60-day follow-up period of participants with influenza virus infection (including influenza
      A subtypes such as H3N2 and 2009 H1N1, or influenza B), or a targeted non-influenza
      respiratory virus, who are hospitalized with severe illness and/or complications in
      geographically diverse locations.

      Specific objectives related to influenza virus infection are to estimate the percentage of
      participants who go on to develop severe disease or complications that require
      hospitalization; to obtain information on risk factors for disease severity; and to establish
      a central repository of specimens for use in virus characterization, including subtyping,
      antigenic and genetic analyses, identification of signature mutations associated with
      antiviral drug resistance, mutational evolution, and additional reassortment.

      Specific objectives related to novel non-influenza respiratory viruses of potential major
      public health importance are to characterize initial cases and their outcomes in order to
      develop more specific protocols that could inform the prevention and treatment of these new
      infections.

      The information used from this study on participants with influenza and novel respiratory
      virus infections will be rapidly analyzed and shared broadly in order to guide policymakers
      and to design future studies.

      Approximately 500 patients with influenza will be enrolled each year at an estimated 75 sites
      which are in geographically diverse locations across several continents.

      Study Plan:

        -  Participants who meet the eligibility criteria will be enrolled at participating
           clinical sites.

        -  Patients with a diagnosis of influenza (confirmed or suspected), who are hospitalized
           with complications or severe disease, will be enrolled.

        -  At enrollment, consent is signed and information (demographics, medical history
           (including prior influenza and pneumococcal vaccination), medications (including
           antivirals) and treatments prescribed) will be recorded. A blood sample for serum and
           plasma will be obtained at enrollment, as well as an upper respiratory tract sample and
           lower respiratory tract sample, if appropriate. The respiratory specimens will be sent
           for central reverse transcriptase polymerase chain reaction (RT-PCR) testing for
           influenza.

        -  For participants who are still hospitalized, and not intubated, 5 to 7 days after
           enrollment an additional upper respiratory sample is obtained.

        -  Status will be re-assessed at approximately 28 days and 60 days after enrollment and
           another blood sample for serum and plasma will obtained at both time points.

        -  For participants who are mechanically ventilated additional upper and lower respiratory
           tract specimens will be obtained at specific timepoints.

      In February 2012, the FLU 004 Genomics protocol v 1.0 was released to the field. In August
      2013, v 2.0 of the protocol was released as INSIGHT Genomics. The protocol was expanded
      beyond the FLU 002 and FLU 003 studies to include all qualifying INSIGHT studies (list of
      qualifying studies is posted on the INSIGHT website, www.insight-trials.org). The purpose of
      this substudy is to obtain a whole blood sample from which DNA will be extracted to study
      polymorphisms in immune response genes and other genetic variants that may be associated with
      an increased risk of severe influenza.

      Participating FLU 003 Plus sites are given the option to also participate in INSIGHT Genomics
      which requires a separate protocol registration. Participants, once consented to FLU 003
      Plus, will be offered the option to also consent to INSIGHT Genomics which includes a single
      whole blood sample collection. Participation in FLU 003 Plus will not be compromised if a
      participant opts not to participate in INSIGHT Genomics.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 2009</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Death</measure>
    <time_frame>60-day period following enrollment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recovery from influenza illness (including days lost from normal activities) duration of hospitalization, days in intensive care, days of mechanical ventilation, days of dialysis, pregnancy outcome</measure>
    <time_frame>approximately 60 days</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Influenza</condition>
  <condition>Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV)</condition>
  <condition>Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)</condition>
  <arm_group>
    <arm_group_label>Influenza</arm_group_label>
    <description>Influenza A and subtypes such as H3N2 and 2009 H1N1 or influenza B</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Novel Respiratory Virus-1</arm_group_label>
    <description>MERS-CoV (Middle East Respiratory Syndrome Coronavirus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Novel Respiratory Virus-2</arm_group_label>
    <description>SARS-CoV (Severe Acute Respiratory Syndrome Coronavirus)</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum, plasma, respiratory for all participants. For participants with a confirmed targeted
      non-influenza respiratory virus, attempts will be made to obtain a sample of the local
      specimen used to confirm diagnosis.

      Whole blood for human genomics (only for FLU 003 Plus sites opting to also participate in
      INSIGHT Genomics and participant has signed an additional consent)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients who are hospitalized with a diagnosis (confirmed or suspected) of influenza
        or a targeted non-influenza viral respiratory infection, as soon as possible after the
        suspected diagnosis is made. Participants may have already been admitted to the hospital at
        the study site or may have been previously seen at another hospital where the diagnosis of
        influenza or infection with a targeted respiratory virus was made.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be â‰¥ 18 years of age

          -  Have been admitted to hospital

          -  Have a signed informed consent by participant or surrogate/representative

          -  Have a local diagnosis (confirmed or suspected) of influenza, or of a targeted
             non-influenza viral respiratory infection*, resulting in (or extending a previous)
             hospitalization

               -  A list of targeted non-influenza respiratory viruses is maintained on the INSIGHT
                  website.

        Exclusion Criteria:

          -  Current imprisonment, or compulsory detention (involuntary incarceration) for treat of
             a psychiatric or physical illness.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>James Neaton, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota - Dept Biostatistics</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>James Neaton, Professor</last_name>
    <phone>612-626-9040</phone>
    <email>neato001@umn.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kate Brekke, Coordinator</last_name>
    <phone>612-626-8615</phone>
    <email>kahlgren@umn.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UCSD Antiviral Research Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103-8208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Schooley, MD</last_name>
      <phone>619-543-8080</phone>
      <email>rschooley@ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Schooley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>George Washington Medical Faculty Associates</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gary L. Simon, MD, PhD</last_name>
      <phone>202-741-2234</phone>
      <email>gsimon@mfa.gwu.edu</email>
    </contact>
    <investigator>
      <last_name>Gary L. Simon, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington DC VA Medical Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20422</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fred M. Gordin, MD</last_name>
      <phone>202-745-8301</phone>
      <email>fred.gordin@va.gov</email>
    </contact>
    <investigator>
      <last_name>Fred M. Gordin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Illinois at Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard M. Novak, MD</last_name>
      <phone>312-996-6763</phone>
      <email>rmnovak@uic.edu</email>
    </contact>
    <investigator>
      <last_name>Richard M. Novak, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Namrata Patil, MD, MPH</last_name>
      <phone>617-732-8042</phone>
      <email>npatil@partners.org</email>
    </contact>
    <investigator>
      <last_name>Namrata Patil, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baystate Infectious Diseases Clinical Research</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <zip>01199</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amando Paez</last_name>
      <email>amando.paez@baystatehealth.org</email>
    </contact>
    <investigator>
      <last_name>Amando Paez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norman Markowitz, MD</last_name>
      <phone>313-916-2575</phone>
      <email>nmarkow1@hfhs.org</email>
    </contact>
    <investigator>
      <last_name>Norman Markowitz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zelalem Temesgen, MD</last_name>
      <phone>507-255-7938</phone>
      <email>temesgen.zelalem@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Zelalem Temesgen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cooper University Hospital</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raquel Nahra, MD</last_name>
      <phone>856-757-7843</phone>
      <email>nahra-raquel@cooperhealth.edu</email>
    </contact>
    <investigator>
      <last_name>Raquel Nahra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New Jersey Medical School Adult Clinical Research Center</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nila Dharan, MD</last_name>
      <phone>973-972-2614</phone>
      <email>dharannj@njms.rutgers.edu</email>
    </contact>
    <investigator>
      <last_name>Nila Dharan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Riska, M.D.</last_name>
      <phone>718-920-6494</phone>
      <email>priska@montefiore.org</email>
    </contact>
    <investigator>
      <last_name>Paul Riska, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cornell CRS</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roy Gulick, MD</last_name>
      <email>rgulick@med.cornell.edu</email>
    </contact>
    <investigator>
      <last_name>Roy Gulick, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cameron Wolfe</last_name>
      <email>cameron.wolfe@dm.duke.edu</email>
    </contact>
    <investigator>
      <last_name>Cameron Wolfe</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Ohio State University Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan L. Koletar, MD</last_name>
      <phone>614-293-5666</phone>
      <email>koletar.1@osu.edu</email>
    </contact>
    <investigator>
      <last_name>Susan L. Koletar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Miami Valley Hospital</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45409</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hari Polenakovik, MD</last_name>
      <phone>937-208-2873</phone>
      <email>hmpolenako@premierhealth.com</email>
    </contact>
    <investigator>
      <last_name>Hari Polenakovik, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Tennessee College of Medicine</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Gunter, MD</last_name>
      <email>icudoc.john@gmail.com</email>
    </contact>
    <investigator>
      <last_name>John Gunter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel E. Nixon, DO, PhD</last_name>
      <phone>804-828-4510</phone>
      <email>dnixon@mcvh-vcu.edu</email>
    </contact>
    <investigator>
      <last_name>Daniel E. Nixon, DO, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Beilke</last_name>
      <email>mbeilke@mcw.edu</email>
    </contact>
    <investigator>
      <last_name>Mark Beilke</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Nacional Profesor Alejandro Posadas</name>
      <address>
        <city>El Palomar</city>
        <state>Buenos Aires</state>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Instituto Medico Platense</name>
      <address>
        <city>La Plata</city>
        <state>Buenos Aires</state>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Analia Mykietiuk</last_name>
      <email>analiamykietiuk@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Analia Mykietiuk</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Austral</name>
      <address>
        <city>Pilar</city>
        <state>Buenos Aires</state>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rodolfo Quiros, MD</last_name>
      <email>quiros.re@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Rodolfo Quiros, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Profesor Bernardo Houssay</name>
      <address>
        <city>Vicente Lopez</city>
        <state>Buenos Aires</state>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gustavo Da Lopardo, MD</last_name>
      <phone>54.11.48094206</phone>
      <email>glopardo@intramed.net.ar</email>
    </contact>
    <investigator>
      <last_name>Gustavo Da Lopardo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sanatorio Britanico</name>
      <address>
        <city>Rosario</city>
        <state>Santa Fe</state>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Esteban Ca Nannini, MD</last_name>
      <email>esteban.nannini@sanbritanico.com.ar</email>
    </contact>
    <investigator>
      <last_name>Esteban Ca Nannini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CEMIC</name>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pablo Bonvehi</last_name>
      <email>pbonvehi@intramed.net.ar</email>
    </contact>
    <investigator>
      <last_name>Pablo Bonvehi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General de Agudos JM Ramos Mejia</name>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcelo H. Losso, MD</last_name>
      <phone>54.11.49315252</phone>
      <email>mlosso@hivramos.org.ar</email>
    </contact>
    <investigator>
      <last_name>Marcelo H. Losso, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Interzonal General de Agudos Dr. Diego Paroissien</name>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Italiano de Buenos Aires</name>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Barcan</last_name>
      <phone>54.11.49590200</phone>
      <phone_ext>8677</phone_ext>
      <email>laura.barcan@hospitalitaliano.org.ar</email>
    </contact>
    <investigator>
      <last_name>Laura Barcan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Privado Centro Medico de Cordoba</name>
      <address>
        <city>Cordoba</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abel Hu Zarate</last_name>
      <email>ahzarate@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Abel Hu Zarate</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Rawson</name>
      <address>
        <city>Cordoba</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Om David, MD</last_name>
      <phone>54.351.6969363</phone>
      <email>danielo.david@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Daniel Om David, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Vincent's Hospital</name>
      <address>
        <city>Darlinghurst</city>
        <state>New South Wales</state>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David A. Cooper, MD, DSc</last_name>
      <phone>61.2.9385.0900</phone>
      <email>dcooper@nchecr.unsw.edu.au</email>
    </contact>
    <investigator>
      <last_name>David A. Cooper, MD, DSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Westmead Hospital</name>
      <address>
        <city>Westmead</city>
        <state>New South Wales</state>
        <zip>2145</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominic Dwyer</last_name>
      <phone>61.2.9845.6694</phone>
      <email>dominic.dwyer@sydney.edu.au</email>
    </contact>
    <investigator>
      <last_name>Dominic Dwyer</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Alfred Hospital</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julian Elliott</last_name>
      <email>julian.elliott@alfred.org.au</email>
    </contact>
    <investigator>
      <last_name>Julian Elliott</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire St. Pierre (C.H.U. St. Pierre)</name>
      <address>
        <city>Brussels</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nathan Clumeck, MD, PhD</last_name>
      <phone>32.2.535.41.31</phone>
      <email>infectiousdiseases@stpierre-bru.be</email>
    </contact>
    <investigator>
      <last_name>Nathan Clumeck, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinica Alemana</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Fundacion Arriaran</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Arhus Universitetshospital, Skejby</name>
      <address>
        <city>Aarhus</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars Oestergaard, MD,PhD, DMSc</last_name>
      <phone>45.89.49.84.93</phone>
      <email>larsoest@rm.dk</email>
    </contact>
    <investigator>
      <last_name>Lars Oestergaard, MD,PhD, DMSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHIP</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jens D. Lundgren, MD, DMSc</last_name>
      <phone>45.35.45.57.51</phone>
      <email>jens.lundgren@regionh.dk</email>
    </contact>
    <investigator>
      <last_name>Jens D. Lundgren, MD, DMSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hvidovre University Hospital, Department of Infectious Diseases</name>
      <address>
        <city>Hvidovre</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gitte Kronborg</last_name>
      <email>gkronborg@dadlnet.dk</email>
    </contact>
    <investigator>
      <last_name>Gitte Kronborg</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Svend Stenvang Pedersen</last_name>
      <email>svend.stenvang@ouh.regionsyddanmark.dk</email>
    </contact>
    <investigator>
      <last_name>Svend Stenvang Pedersen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Universitatsklinik - Bonn, Immunologische Ambulanz CRS</name>
      <address>
        <city>Bonn</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jurgen Rockstroh</last_name>
      <phone>49.228.287.16558</phone>
      <email>rockstroh@uni-bonn.de</email>
    </contact>
    <investigator>
      <last_name>Jurgen Rockstroh</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinik I fur Innere Medizin der Universitat zu Koln, Studienburo fur Infektiologie u. HIV</name>
      <address>
        <city>Cologne</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerd Fatkenheuer, MD</last_name>
      <phone>49.221.478.5860</phone>
      <email>gerd.faetkenheuer@uk-koeln.de</email>
    </contact>
    <investigator>
      <last_name>Gerd Fatkenheuer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johann Wolfgang Goethe - University Hospital, Infektionsambulanz CRS</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Stephan</last_name>
      <phone>49.696.301.7680</phone>
      <email>christoph.stephan@hivcenter.de</email>
    </contact>
    <investigator>
      <last_name>Christoph Stephan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>1st Dept of Critical Care Medicine and Pulmonary Services, Evangelismos Hospital</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ioannis Kalomenidis</last_name>
      <email>ikalom@med.uoa.gr</email>
    </contact>
    <investigator>
      <last_name>Ioannis Kalomenidis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>1st Respiratory Medicine Dept, Athens Hosp for Diseases of the Chest &quot;Sotiria Hospital&quot;</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nikolaos Koulouris</last_name>
      <email>koulnik@med.uoa.gr</email>
    </contact>
    <investigator>
      <last_name>Nikolaos Koulouris</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Evangelismos General Hospital</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Athanasios Skoutelis</last_name>
      <phone>30.2107201830</phone>
      <email>skoute1@otenet.gr</email>
    </contact>
    <investigator>
      <last_name>Athanasios Skoutelis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hippokration University General Hospital of Athens</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helen Sambatakou, MD, PhD</last_name>
      <phone>30.2132088727</phone>
      <email>helensambatakou@msn.com</email>
    </contact>
    <investigator>
      <last_name>Helen Sambatakou, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Nacional Arzobispo Loayza</name>
      <address>
        <city>Lima</city>
        <zip>01</zip>
        <country>Peru</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yvett Pinedo</last_name>
      <email>ypinedor@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Yvett Pinedo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Nacional Guillermo Almenara Irigoyen</name>
      <address>
        <city>Lima</city>
        <zip>13</zip>
        <country>Peru</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Vega</last_name>
      <email>jvegaorama@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Juan Vega</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico San Carlos</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vicente Estrada, MD</last_name>
      <phone>34.60.929.28.82</phone>
      <email>vestrada.hcsc@salud.madrid.org</email>
    </contact>
    <investigator>
      <last_name>Vicente Estrada, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital La Paz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Ra Pano-Pardo</last_name>
      <phone>34.63.058.51.11</phone>
      <email>joserrapa@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Jose Ra Pano-Pardo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Gregorio Maraï¿½on</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eduardo Fernandez-Cruz, MD, PhD</last_name>
      <phone>34.60.716.84.70</phone>
      <email>eduardo.fernandezcruz@salud.madrid.org</email>
    </contact>
    <investigator>
      <last_name>Eduardo Fernandez-Cruz, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Infanta Leonor</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pablo Ryan, MD</last_name>
      <phone>34.61.683.21.48</phone>
      <email>pabloryan@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Pablo Ryan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Txagorritxu</name>
      <address>
        <city>Vitoria-Gasteiz</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Lu Lobo</last_name>
      <email>joseluis.loboberistain@osakidetza.net</email>
    </contact>
    <investigator>
      <last_name>Jose Lu Lobo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chulalongkorn University Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kiat Ruxrungtham, MD, MSc</last_name>
      <phone>66.2.2564638</phone>
      <email>rkiat@chula.ac.th</email>
    </contact>
    <investigator>
      <last_name>Kiat Ruxrungtham, MD, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Khon Kaen University, Srinagarind Hospital</name>
      <address>
        <city>Khon Kaen</city>
        <zip>40002</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ploenchan Chetchotisakd, MD</last_name>
      <phone>66.43.348399</phone>
      <email>ploencha@kku.ac.th</email>
    </contact>
    <investigator>
      <last_name>Ploenchan Chetchotisakd, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bamrasnaradura Institute</name>
      <address>
        <city>Nonthaburi</city>
        <zip>11000</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weerawat Manosuthi</last_name>
      <email>drweerawat@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Weerawat Manosuthi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Heatherwood and Wexham Park Hospitals NHS Foundation Trust</name>
      <address>
        <city>Slough</city>
        <state>Berkshire</state>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane Democratis</last_name>
      <email>jane.democratis@hwph-tr.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Jane Democratis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Brighton and Sussex University Hospitals NHS Trust</name>
      <address>
        <city>Brighton</city>
        <state>East Sussex</state>
        <zip>BN2 1ES</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melanie Newport</last_name>
      <phone>44.1273.877882</phone>
      <email>m.j.newport@bsms.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Melanie Newport</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Churchill Hospital</name>
      <address>
        <city>Headington</city>
        <state>Oxford</state>
        <zip>OX3 9LJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brian J. Angus, MD</last_name>
      <phone>44.1865.220289</phone>
      <email>brian.angus@ndm.ox.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Brian J. Angus, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sheffield Teaching Hospital NHS Foundation Trust</name>
      <address>
        <city>Sheffield</city>
        <state>South Yorkshire</state>
        <zip>S10 2JF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Dockrell, MD, FRCPI</last_name>
      <phone>44.114.226.1427</phone>
      <email>d.h.dockrell@sheffield.ac.uk</email>
    </contact>
    <investigator>
      <last_name>David Dockrell, MD, FRCPI</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bradford Teaching Hospitals NHS Foundation Trust</name>
      <address>
        <city>Bradford</city>
        <state>West Yorkshire</state>
        <zip>BD9 6RJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ben Jeffs</last_name>
      <email>ben.jeffs@bthft.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Ben Jeffs</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St James's University Hospital</name>
      <address>
        <city>Leeds</city>
        <state>West Yorkshire</state>
        <zip>LS9 7TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jane Minton</last_name>
      <email>jane.minton@leedsth.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Jane Minton</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Newcastle General Hospital</name>
      <address>
        <city>Newcastle upon Tyne</city>
        <zip>NE4 6BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Price</last_name>
      <email>david.price@nuth.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Ashley Price</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Belgium</country>
    <country>Chile</country>
    <country>Denmark</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Peru</country>
    <country>Spain</country>
    <country>Thailand</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Austria</country>
    <country>China</country>
    <country>Norway</country>
    <country>Poland</country>
    <country>South Africa</country>
  </removed_countries>
  <link>
    <url>http://www.insight-trials.org</url>
    <description>INSIGHT website</description>
  </link>
  <reference>
    <citation>Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009 Jun 18;360(25):2605-15. doi: 10.1056/NEJMoa0903810. Epub 2009 May 7. Erratum in: N Engl J Med. 2009 Jul 2;361(1):102.</citation>
    <PMID>19423869</PMID>
  </reference>
  <reference>
    <citation>World Health Organization (WHO), www.who.int/, accessed 26 August 2013</citation>
  </reference>
  <reference>
    <citation>Guery B, Poissy J, el Mansouf L, SÃ©journÃ© C, Ettahar N, Lemaire X, Vuotto F, Goffard A, Behillil S, Enouf V, Caro V, Mailles A, Che D, Manuguerra JC, Mathieu D, Fontanet A, van der Werf S; MERS-CoV study group. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet. 2013 Jun 29;381(9885):2265-72. doi: 10.1016/S0140-6736(13)60982-4. Epub 2013 May 30. Erratum in: Lancet. 2013 Jun 29;381(9885):2254.</citation>
    <PMID>23727167</PMID>
  </reference>
  <reference>
    <citation>Drosten C, Seilmaier M, Corman VM, Hartmann W, Scheible G, Sack S, Guggemos W, Kallies R, Muth D, Junglen S, MÃ¼ller MA, Haas W, Guberina H, RÃ¶hnisch T, Schmid-Wendtner M, Aldabbagh S, Dittmer U, Gold H, Graf P, Bonin F, Rambaut A, Wendtner CM. Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis. 2013 Sep;13(9):745-51. doi: 10.1016/S1473-3099(13)70154-3. Epub 2013 Jun 17.</citation>
    <PMID>23782859</PMID>
  </reference>
  <reference>
    <citation>World Health Organization (WHO), Severe Acute Respiratory Syndrome (SARS), www.who.int/csr/sars/, accessed 26 August 2013</citation>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2010</study_first_submitted>
  <study_first_submitted_qc>January 25, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2010</study_first_posted>
  <last_update_submitted>February 22, 2018</last_update_submitted>
  <last_update_submitted_qc>February 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>influenza</keyword>
  <keyword>flu</keyword>
  <keyword>swine flu</keyword>
  <keyword>respiratory virus</keyword>
  <keyword>hospitalization</keyword>
  <keyword>MERS-CoV</keyword>
  <keyword>SARS-CoV</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Virus Diseases</mesh_term>
    <mesh_term>Influenza, Human</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
    <mesh_term>Coronavirus Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

